August 23, 2018 from ObGynNews The management of bipolar disorder during pregnancy is a critical clinical situation demanding great attention to issues such as reproductive safety of psychiatric medications used by women with bipolar disorder [...]
Need a new search?
If you didn't find what you were looking for, try a new search!
While some women with bipolar disorder elect to discontinue their psychotropic medications during pregnancy to mitigate fetal exposure, Viguera and colleagues (2000, 2007) found that women stabilized on lithium face a significant risk for [...]
Numerous studies have demonstrated that women with histories of bipolar disorder are at high risk for postpartum illness. Because of this increased risk for relapse during the postpartum period, we typically recommend that women with [...]
When we meet women for consultations regarding the use of psychotropic medications during pregnancy, we focus primarily on the impact of medications on the developing fetus and the pregnancy. However, we need also to address [...]
Ms. C is a woman with a long history of bipolar disorder, dating back to her teen years. Because she experienced recurrent hypomania and mania every time she attempted to discontinue her treatment, she and [...]
Various studies have demonstrated that women with histories of either bipolar disorder or postpartum psychosis are at high risk for postpartum relapse. While we recognize the risk as being “high”, estimations of the risk for [...]
Women with bipolar disorder are at significant risk for recurrent illness during the postpartum period. After miscarriage, an event which is associated with both hormonal changes and psychological complexity, is the risk for recurrent illness [...]
Women with bipolar disorder (BD) are at extremely high risk for postpartum psychiatric illness, specifically postpartum psychosis. While the American College of Obstetrics and Gynecology now recommends that all women be screened for depression during [...]
Conference News from ECNP: High Risk of Psychopathology in the Offspring of Parents with Bipolar Disorder and Schizophrenia
Children whose parents have either schizophrenia or bipolar disorder are at high risk for psychopathology. There are genetic factors which influence vulnerability to illness, but environmental influences also play a role. Data presented at the [...]
Choosing whether to maintain or discontinue mood stabilizer treatment during pregnancy requires weighing the risks of teratogenic outcomes associated with exposure to a particular drug against the risks of recurrence of untreated affective illness. However, [...]